Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined Afirma Genomic Sequencing Classifier and TERT promoter mutation detection in molecular assessment of Bethesda III-VI thyroid nodules.

Cancer cytopathology - 1 Oct 2023

Ladenson Paul W, Klopper Joshua P, Hao Yangyang, Kaushik Praveen, Walsh P Sean, Huang Jing, Kloos Richard T, Ali Syed Z

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Profiling
Share to Genomics
Share to Head and Neck Anomalies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Telomerase

Share to Thyroid Cancer Diagnosis and Treatment

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Identifiers

PMID: 37544986
DOI: 10.1002/cncy.22744

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined Afirma Genomic Sequencing Classifier and TERT promoter mutation detection in molecular assessment of Bethesda III-VI thyroid nodules.PMID 37544986Read ↗

Clinical use of Molecular Data in Thyroid Nodules and CancerSemantic proximity Read ↗

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read ↗

Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.Semantic proximity Read ↗

Current State of Molecular Cytology in Thyroid Nodules: Platforms and their Diagnostic and Theranostic UtilitySemantic proximity Read ↗

Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.Semantic proximity Read ↗

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.Semantic proximity Read ↗

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.Semantic proximity Read ↗

Utility of molecular testing in the management of thyroid nodules - a clinical perspective.Semantic proximity Read ↗

Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.Semantic proximity Read ↗

Mutation profiles of follicular thyroid tumors by targeted sequencingSemantic proximity Read ↗

Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.Semantic proximity Read ↗

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.